{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:46:24Z","timestamp":1794674784127,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T00:00:00Z","timestamp":1409011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T00:00:00Z","timestamp":1409011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep06189","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T09:07:59Z","timestamp":1409044079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Methadone induces testosterone suppression in patients with opioid addiction"],"prefix":"10.1038","volume":"4","author":[{"given":"Monica","family":"Bawor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Constantine","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Plater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Worster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Varenbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Daiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Anglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Pare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,26]]},"reference":[{"key":"BFsrep06189_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/16066359909004395","volume":"7","author":"B Fischer","year":"1999","unstructured":"Fischer, B., Medved, W., Gliksman, L. & Rehm, J. Illicit opiate users in Toronto: a profile of current users. Addict Res 7, 377\u2013415 (1999).","journal-title":"Addict Res"},{"key":"BFsrep06189_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1503\/cmaj.060729","volume":"175","author":"B Fischer","year":"2006","unstructured":"Fischer, B., Rehm, J., Patra, J. & Cruz, M. F. Changes in illicit opioid use across Canada. CMAJ 175, 1385, 10.1503\/cmaj.060729 (2006).","journal-title":"CMAJ"},{"key":"BFsrep06189_CR3","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Household Survey on Drug Abuse, 2000. Ann Arbor, MI: Inter-university Consortium for Political and Social Research, 10.3886\/ICPSR03262.v5 (2013). Date of access: 25\/02\/2014."},{"key":"BFsrep06189_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/00952990.2011.596982","volume":"37","author":"SE Back","year":"2011","unstructured":"Back, S. E. et al. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. Am J Drug Alcohol Ab 37, 313\u2013323 (2011).","journal-title":"Am J Drug Alcohol Ab"},{"key":"BFsrep06189_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/02791072.2010.10399789","volume":"42","author":"I Maremmani","year":"2010","unstructured":"Maremmani, I. et al. Differential substance abuse patterns distribute according to gender in heroin addicts. J Psychoactive Drugs 42, 89\u201395 (2010).","journal-title":"J Psychoactive Drugs"},{"key":"BFsrep06189_CR6","first-page":"172","volume":"21","author":"CK Chen","year":"1998","unstructured":"Chen, C. K., Shu, L. W., Liang, P. L., Hung, T. M. & Lin, S. K. Drug use patterns and gender differences among heroin addicts hospitalized for detoxification. Changgeng Yi Xue Za Zhi 21, 172\u2013178 (1998).","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"BFsrep06189_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/10550887.2013.795466","volume":"32","author":"HC Lin","year":"2013","unstructured":"Lin, H. C. et al. Gender differences in heroin users receiving methadone maintenance therapy in Taiwan. J Addict Dis 32, 140\u2013149, 10.1080\/10550887.2013.795466 (2013).","journal-title":"J Addict Dis"},{"key":"BFsrep06189_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.addbeh.2011.03.013","volume":"36","author":"SE Back","year":"2011","unstructured":"Back, S. E., Lawson, K. M., Singleton, L. M. & Brady, K. T. Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav 36, 829\u2013834, 10.1016\/j.addbeh.2011.03.013 (2011).","journal-title":"Addict Behav"},{"key":"BFsrep06189_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3109\/10826089909039401","volume":"34","author":"LR Chatham","year":"1999","unstructured":"Chatham, L. R., Hiller, M. L., Rowan-Szal, G. A., Joe, G. W. & Simpson, D. D. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse 34, 1137\u20131165 (1999).","journal-title":"Subst Use Misuse"},{"key":"BFsrep06189_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/070674370605101002","volume":"51","author":"B Fischer","year":"2006","unstructured":"Fischer, B., Cruz, M. F. & Rehm, J. Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiat 51, 624\u2013634 (2006).","journal-title":"Can J Psychiat"},{"key":"BFsrep06189_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/0022-4731(76)90050-9","volume":"7","author":"WE Stumpf","year":"1976","unstructured":"Stumpf, W. E. & Sar, M. Steroid hormone target sites in the brain: the differential distribution of estrogin, progestin, androgen and glucocorticosteroid. J Steroid Biochem 7, 1163\u20131170 (1976).","journal-title":"J Steroid Biochem"},{"key":"BFsrep06189_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(25)30047-9","volume":"192","author":"JH Mendelson","year":"1975","unstructured":"Mendelson, J. H., Mendelson, J. E. & Patch, V. D. Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 192, 211\u2013217 (1975).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep06189_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0306-4530(01)00035-X","volume":"27","author":"TA Kosten","year":"2002","unstructured":"Kosten, T. A. & Ambrosio, E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrino 27, 35\u201369 (2002).","journal-title":"Psychoneuroendocrino"},{"key":"BFsrep06189_CR14","first-page":"Es145","volume":"15","author":"HS Smith","year":"2012","unstructured":"Smith, H. S. & Elliott, J. A. Opioid-induced androgen deficiency (OPIAD). Pain Physician 15, Es145\u2013156 (2012).","journal-title":"Pain Physician"},{"key":"BFsrep06189_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/00126334-200010001-00005","volume":"25 Suppl 1","author":"JT Wahlstrom","year":"2000","unstructured":"Wahlstrom, J. T. & Dobs, A. S. Acute and long-term effects of AIDS and injection drug use on gonadal function. J Acquir Immune Defic Syndr 25 Suppl 1, S27\u201336 (2000).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFsrep06189_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","volume":"25","author":"N Katz","year":"2009","unstructured":"Katz, N. & Mazer, N. A. The impact of opioids on the endocrine system. Clin J Pain 25, 170\u2013175, 10.1097\/AJP.0b013e3181850df6 (2009).","journal-title":"Clin J Pain"},{"key":"BFsrep06189_CR17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin, S. et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91, 1995\u20132010, 10.1210\/jc.2005-2847 (2006).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep06189_CR18","first-page":"2551","volume":"39","author":"TJ Cicero","year":"1980","unstructured":"Cicero, T. J. Effects of exogenous and endogenous opiates on the hypothalamic--pituitary--gonadal axis in the male. Fed Proc 39, 2551\u20132554 (1980).","journal-title":"Fed Proc"},{"key":"BFsrep06189_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","volume":"9","author":"HW Daniell","year":"2008","unstructured":"Daniell, H. W. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 9, 28\u201336, 10.1016\/j.jpain.2007.08.005 (2008).","journal-title":"J Pain"},{"key":"BFsrep06189_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/endo-109-3-776","volume":"109","author":"SP Kalra","year":"1981","unstructured":"Kalra, S. P. & Simpkins, J. W. Evidence for noradrenergic mediation of opioid effects on luteinizing hormone secretion. Endocrinology 109, 776\u2013782 (1981).","journal-title":"Endocrinology"},{"key":"BFsrep06189_CR21","first-page":"216","volume":"81","author":"G Woody","year":"1988","unstructured":"Woody, G. et al. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monogr 81, 216\u2013223 (1988).","journal-title":"NIDA Res Monogr"},{"key":"BFsrep06189_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0885-3924(03)00331-2","volume":"26","author":"A Rajagopal","year":"2003","unstructured":"Rajagopal, A., Vassilopoulou-Sellin, R., Palmer, J. L., Kaur, G. & Bruera, E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 26, 1055\u20131061 (2003).","journal-title":"J Pain Symptom Manage"},{"key":"BFsrep06189_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0885-3924(94)90166-X","volume":"9","author":"JA Paice","year":"1994","unstructured":"Paice, J. A., Penn, R. D. & Ryan, W. G. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 9, 126\u2013131 (1994).","journal-title":"J Pain Symptom Manage"},{"key":"BFsrep06189_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0015-0282(16)46101-7","volume":"37","author":"R Hemmings","year":"1982","unstructured":"Hemmings, R., Fox, G. & Tolis, G. Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women. Fertil Steril 37, 389\u2013391 (1982).","journal-title":"Fertil Steril"},{"key":"BFsrep06189_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0300-483X(79)90016-7","volume":"15","author":"G Bolelli","year":"1979","unstructured":"Bolelli, G. et al. Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH and the plasma concentration of heroin. Toxicology 15, 19\u201329 (1979).","journal-title":"Toxicology"},{"key":"BFsrep06189_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jpainsymman.2010.06.021","volume":"41","author":"R Dev","year":"2011","unstructured":"Dev, R. et al. Association between serum cortisol and testosterone levels, opioid therapy and symptom distress in patients with advanced cancer. J Pain Symptom Manage 41, 788\u2013795, 10.1016\/j.jpainsymman.2010.06.021 (2011).","journal-title":"J Pain Symptom Manage"},{"key":"BFsrep06189_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/JCP.0b013e3181a39113","volume":"29","author":"AK Elkader","year":"2009","unstructured":"Elkader, A. K., Brands, B., Selby, P. & Sproule, B. A. Methadone-nicotine interactions in methadone maintenance treatment patients. J Clin Psychopharmacol 29, 231\u2013238, 10.1097\/JCP.0b013e3181a39113 (2009).","journal-title":"J Clin Psychopharmacol"},{"key":"BFsrep06189_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/pmed.1999.0605","volume":"30","author":"RD Burt","year":"2000","unstructured":"Burt, R. D., Dinh, K. T., Peterson, A. V., Jr & Sarason, I. G. Predicting adolescent smoking: a prospective study of personality variables. Prev Med 30, 115\u2013125, 10.1006\/pmed.1999.0605 (2000).","journal-title":"Prev Med"},{"key":"BFsrep06189_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2105\/AJPH.91.2.296","volume":"91","author":"KP Richter","year":"2001","unstructured":"Richter, K. P., Gibson, C. A., Ahluwalia, J. S. & Schmelzle, K. H. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 91, 296\u2013299 (2001).","journal-title":"Am J Public Health"},{"key":"BFsrep06189_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1754-3207(11)70613-7","volume":"5","author":"G Borjesson","year":"2011","unstructured":"Borjesson, G., Martensson, A., Holmer, H. I. & Westerling, D. Low testosterone levels in men with long-term opioid treatment. Eur J Pain Suppl 5, 178 (2011).","journal-title":"Eur J Pain Suppl"},{"key":"BFsrep06189_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0924-9338(98)80011-4","volume":"13","author":"A Dazord","year":"1998","unstructured":"Dazord, A., Mino, A., Page, D. & Broers, B. Patients on methadone maintenance treatment in Geneva. Eur Psychiat 13, 235\u2013241, 10.1016\/s0924-9338(98)80011-4 (1998).","journal-title":"Eur Psychiat"},{"key":"BFsrep06189_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/00016349109007163","volume":"70","author":"L Anttila","year":"1991","unstructured":"Anttila, L., Koskinen, P., Irjala, K. & Kaihola, H. L. Reference intervals for serum sex steroids and gonadotropins in regularly menstruating women. Acta Obstet Gynecol Scand 70, 475\u2013481 (1991).","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BFsrep06189_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF03348533","volume":"8","author":"MB Mathor","year":"1985","unstructured":"Mathor, M. B., Achado, S. S., Wajchenberg, B. L. & Germek, O. A. Free plasma testosterone levels during the normal menstrual cycle. J Endocrinol Invest 8, 437\u2013441 (1985).","journal-title":"J Endocrinol Invest"},{"key":"BFsrep06189_CR34","first-page":"177","volume-title":"Steroids","author":"MS Rothman","year":"2011","unstructured":"Rothman, M. S. et al. in Steroids 76, 177\u2013182 (2010 Elsevier Inc, 2011)."},{"key":"BFsrep06189_CR35","first-page":"112","volume":"68","author":"F Stahl","year":"1976","unstructured":"Stahl, F., Dorner, G., Rohde, W. & Schott, G. Total and free testosterone and total and free 17 beta-oestradiol in normally menstruating women. Endokrinologie 68, 112\u2013114 (1976).","journal-title":"Endokrinologie"},{"key":"BFsrep06189_CR36","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1111\/j.1743-6109.2011.02380.x","volume":"8","author":"GD Braunstein","year":"2011","unstructured":"Braunstein, G. D., Reitz, R. E., Buch, A., Schnell, D. & Caulfield, M. P. Testosterone reference ranges in normally cycling healthy premenopausal women. J Sex Med 8, 2924\u20132934, 10.1111\/j.1743-6109.2011.02380.x (2011).","journal-title":"J Sex Med"},{"key":"BFsrep06189_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/cs20020360","volume":"105","author":"KJ Elliott","year":"2003","unstructured":"Elliott, K. J., Cable, N. T., Reilly, T. & Diver, M. J. Effect of menstrual cycle phase on the concentration of bioavailable 17-beta oestradiol and testosterone and muscle strength. Clin Sci (Lond) 105, 663\u2013669, 10.1042\/cs20020360 (2003).","journal-title":"Clin Sci (Lond)"},{"key":"BFsrep06189_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1210\/jc.2011-2134","volume":"97","author":"R Haring","year":"2012","unstructured":"Haring, R. et al. Age-Specific Reference Ranges for Serum Testosterone and Androstenedione Concentrations in Women Measured by Liquid Chromatography-Tandem Mass Spectrometry. J Clin Endocr Metab 97, 408\u2013415, 10.1210\/jc.2011-2134 (2012).","journal-title":"J Clin Endocr Metab"},{"key":"BFsrep06189_CR39","first-page":"1","volume":"10","author":"Z Samaan","year":"2014","unstructured":"Samaan, Z. et al. Genetic influence on methadone treatment outcomes in patients undergoing Methadone Maintenance Treatment (MMT) for opioid addiction: A pilot study. In press. Neuropsychiatr Dis Treat 10, 1\u20136 (2014).","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFsrep06189_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-0327(02)00174-X","volume":"78","author":"B Bell","year":"2004","unstructured":"Bell, B. et al. Burden of dysthymia and comorbid illness in adults in a Canadian primary care setting: high rates of psychiatric illness in the offspring. J Affect Disord 78, 73\u201380 (2004).","journal-title":"J Affect Disord"},{"key":"BFsrep06189_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0165-0327(01)00343-3","volume":"68","author":"G Browne","year":"2002","unstructured":"Browne, G. et al. Sertraline and\/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 68, 317\u2013330 (2002).","journal-title":"J Affect Disord"},{"key":"BFsrep06189_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0165-0327(98)00189-X","volume":"54","author":"M Steiner","year":"1999","unstructured":"Steiner, M. et al. Prevalence of dysthymic disorder in primary care. J Affect Disord 54, 303\u2013308 (1999).","journal-title":"J Affect Disord"},{"key":"BFsrep06189_CR43","first-page":"22","volume":"59 Suppl 20","author":"DV Sheehan","year":"1998","unstructured":"Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat 59 Suppl 20, 22\u201333; quiz 34\u201357 (1998).","journal-title":"J Clin Psychiat"},{"key":"BFsrep06189_CR44","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453\u20131457, 10.1016\/s0140-6736(07)61602-x (2007).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep06189","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:22:30Z","timestamp":1746354150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep06189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep06189"],"URL":"https:\/\/doi.org\/10.1038\/srep06189","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,26]]},"assertion":[{"value":"30 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6189"}}